Exhibit 107
Calculation of Filing Fee Tables
Schedule TO
(Form Type)
Coherus BioSciences, Inc.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Transaction Valuation
| Transaction Valuation | Fee rate | Amount of Filing Fee | |
| Fees to Be Paid | $60,067,991.25(1) | 0.00015310(2) | $9,196.41(2) |
| Fees Previously Paid | $0.00 | $0.00 | |
| Total Transaction Valuation | $60,067,991.25 | ||
| Total Fees Due for Filing | $9,196.41 | ||
| Total Fees Previously Paid | $0.00 | ||
| Total Fee Offsets | $0.00 | ||
| Net Fee Due | $9,196.41 |
| (1) | Estimated solely for purposes of calculating the filing fee. The aggregate purchase price of the 1.500% Convertible Senior Subordinated Notes due 2026 (the “Notes”) is calculated as the sum of (a) $59,993,000, representing 100% of the principal amount of the Notes outstanding as of April 16, 2025, plus (b) $74,991.25, representing accrued and unpaid interest on the Notes to, but excluding, May 15, 2025, the repurchase date. |
| (2) | The amount of the filing fee, calculated in accordance with Rule 0-11 under the Securities Exchange Act of 1934, as amended, equals $153.10 per $1,000,000 of the value of the transaction. |